Gene Editing Market Scope And Analysis

Report Code : TIPRE00032626
Category : Life Sciences

No. of Pages : 150

Buy Now

Gene Editing Market Scope and Key Players Analysis by 2030

Buy Now

Gene Editing Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 6,542.95 Million
Market Size by 2030	US$ 23,902.34 Million
Global CAGR (2022 - 2030)	17.6%
Historical Data	2020-2022
Forecast period	2022-2030
Segments Covered	By Component Reagents and Consumables Software and Systems Services By Technology Clustered Regularly Interspaced Short Palindromic Repeats Transcription Activator-Like Effector Nucleases Zinc Finger Nucleases Other Technologies By Application Genetic Engineering and Clinical Applications By End User Pharmaceutical companies and Biotechnology Companies Academics and Government Research Institutes Clinical Research Organizations
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Thermo Fisher Scientific GenScript Lonza Merck KGaA CRISPR Therapeutics PerkinElmer Inc Agilent Technologies Inc Precision Biosciences Sangamo Therapeutics Inc

Industry Developments and Future Opportunities:

Various initiatives taken by key players operating in the global gene editing market are listed below:

In April 2022, Thermo Fisher Scientific introduced the GMP-manufactured Gibco CTS TrueCut Cas9 Protein to help researchers meet stringent quality requirements while using genome editing tools. It is a promising option for CAR T-cell therapy studies using CRISPR-Cas9 genome editing as it consistently provides higher than 90% efficacy in human primary T-cells and high editing effectiveness in all examined cell lines.

Competitive Landscape and Key Companies:

Thermo Fisher Scientific; GenScript; Lonza; Merck KGaA; CRISPR Therapeutics; PerkinElmer Inc.; Agilent Technologies, Inc.; Precision Biosciences; Sangamo Therapeutics, Inc.; New England Biolabs; and Novartis are among the prominent players in the gene editing market. These companies focus on introducing new high-tech products, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.